PPP1R1B and psychiatric disorder: It is well-known that DARPP-32 is crucial for the regulation of transcriptional and behavioral responses to pharmacological agents, including neuroleptics, antidepressants, and drugs of abuse, and it may serve as a therapeutic target in neurological and psychiatric disorders (review, [43]).